Advertisement

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

First International Summit on Interventional Pharmacoeconomics

Advertisement

Related Videos

Deborah Collyar: What's In It for Patients?

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Opportunities to Optimize Cancer Policies Panel Discussion

Advertisement

Advertisement

Jan

08

Today In Oncology

Using AI to Ensure That All Patients With Cancer Have Access to Precision Oncology Care

AI Enhances Detection of Missed Breast Cancers on Screening Tomosynthesis

Hybrid AI Approach With Uncertainty Quantification for Mammography Reading Supports Safe Workload Reduction

AI May Boost Efficacy of Cancer Care but Physicians Remain Critical to Decision Making

Novel AI Platform May Help Identify Patients Likely to Benefit Most From Clinical Trials

Advertisement

© 2026 HSP News Service, L.L.C.